Maximilian Janssen
Papers
1
Total Citations
9
H-Index
1
About
Maximilian Janssen is a leading researcher in urologic oncology, with a primary focus on optimizing surgical outcomes and patient-centered care for prostate cancer. His work centers on the comparative effectiveness of robot-assisted radical prostatectomy (RARP) versus open radical prostatectomy (ORP), with a particular emphasis on patient-reported outcomes. Janssen’s major contribution lies in pioneering the use of patient regret as a critical endpoint for treatment evaluation, moving beyond traditional metrics like recurrence rates to capture the lived experience of patients. His landmark study, the multicenter cross-sectional IMPROVE study (2022, 9 citations), demonstrated that patients undergoing RARP reported significantly less regret regarding their therapy choice compared to those who had ORP. This finding has profound implications for shared decision-making and surgical counseling, highlighting the value of minimally invasive approaches in preserving quality of life. By integrating patient-reported results into surgical research, Janssen has helped shift the field toward more holistic, patient-driven evaluations. His work continues to influence clinical guidelines and inform how surgeons discuss treatment options with men facing prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1